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Endoleak after EVAR
Christopher J. Abularrage, Robert S. Crawford, Mark F. Conrad, Christo-
pher J. Kwolek, Richard P. Cambria, and Glenn M. LaMuraglia, From
Massachusetts General Hospital, Boston, Mass
Objectives: Persistent type 2 endoleaks (PT2) present6months after
endovascular aneurysm repair (EVAR) are associated with adverse out-
comes. This study evaluated the preoperative risk factors and natural history
of PT2 to define a population at high-risk.
Methods: From 1999 to 2007, 595 of 832 (72%) EVAR patients had
long-term computed tomography (CT) follow-up and comprised the study
cohort. Preoperative anatomic and clinical variables were correlated with PT2
using Cox regression and high-risk composite variable analyses. Primary end
points included spontaneous resolution, sac enlargement5mm, and freedom
from reintervention and were evaluated using Kaplan-Meier analysis.
Results: There were 136 (23%) PT2 patients with a median follow-up
of 34.8 months (range, 6.4-121.2 years). Predictive factors included patent
inferior mesenteric artery (IMA; odds ratio [OR], 4.18; 95% confidence
interval [CI], 1.69-10.31; P .002), increasing no of patent lumbar arteries
(OR, 1.25; 95% CI, 1.10-1.42; P  .0006), increasing age (OR, 1.04; 95%
CI, 1.01-1.06; P .003), and increasing aneurysm luminal diameter shown
on CT contrast opacified lumen (OR, 1.03; 95% CI, 1.02-1.05; P .0001).
High-risk composites indicated that patients with a patent IMA and either
Table. Patient comorbidities
Comorbidity % (N  323)
Hypertension 73.7
Coronary artery disease 44.3
Angina 4.3
Arrhythmia 26.9
Myocardial infarction 24.1
Congestive heart failure 7.4
COPD 21.7
Hyperlipidemia 44.9
Renal insufficiency 22.0
Peripheral vascular disease 9.6
Diabetes mellitus 11.1
Stroke 9.6
Smoking 63.2
Cancer 15.5
ASA class II 1.6
ASA class III 78.9
ASA class IV 19.5
ASA, American Society of Anesthesiologists; COPD, chronic obstructive
pulmonary disease
Fig. Freedom from abdominal aortic aneurysm-related death.6 patent lumbar arteries, maximum luminal diameter 30 mm, or age
70 years had an approximately 10-fold increased risk of PT2 (Table).Patients with a patent IMA and any two risk factors had an approximately
20-fold risk. During follow-up, spontaneous PT2 resolution occurred in 35
patients (26%), sac diameter remained stable in 63 (46%), and rupture
occurred in 2 (1.5%). By Kaplan-Meier analysis, 35% of PT2 resolve spon-
taneously and freedom from sac enlargement 5 mm is 55% at 5 years.
Fifty-nine reinterventions were performed in 39 patients with PT2. Freedom
from reintervention was 67% at 5 years.
Conclusions: Readily identifiable preoperative variables are associated
with PT2. High-risk composites can be used to identify a cohort of patients
that should be considered for perioperative interventions to preclude PT2.
Does Renal Transplantation Improve Endovascular Interventional
Outcomes for Patients with Chronic Renal Insufficiency?
Combiz Rezayat,a Ashley Graham,a Habib Khan,a James McKinsey,a
Nicholas Morrisey,a Rajeev Dayal,a Harry Bush,b John Karwowski,b and
Roman Nowygrod,a From Columbia University Medical Centera; and
Weill Cornell Medical College,b New York, NY
Introduction: It has been suggested that preemptive renal transplan-
tation can reduce the incidence and severity of peripheral vascular disease
(PVD) and improve limb salvage. Immunosuppressed transplant patients
may have a decreased incidence of in-stent restenosis. This study compared
limb salvage and patency rates after endovascular interventions among
patients with chronic renal insufficiency (CRI), functional and failed renal
transplants (RT), and normal renal (NR) function.
Methods: A database of 1567 treated lesions from 2004 to 2009 was
cross-referenced with the RT registry for the same period (n 2283) to select
three treated patient groups: NR, 1172; CRI (creatinine 1.2 mg/dL), 349
(end-stage renal disease, 92); RT, 46 (25 functional, 21 failed). Comorbidities
and indications, and primary, secondary patencies, and limb salvage at 6, 12, 18,
24 months were assessed. P was calculated by log-rank analysis.
Results: Indications for interventions were similar for CRI and RT,
comprising claudication, 28 (39%); rest pain, 14 (4%); and tissue loss, 58
(57%). TheNR group hadmore claudicant patients (52%) and less tissue loss
(34%; P  .0001). RT patients were younger than CRI patients and had
lower rates of heart failure. NR patients had a significantly lower incidence of
diabetes than CRI and RT patients (P .002). Primary patency for NR (78%
at 6 months; 50% at 24 months) was significantly better than for CRI (P 
.019 at 6 months; P .002 at 24 months). Primary and secondary patencies
at 6 and 24 months were significantly worse for the RT group than for the
NR group (P .001). Similarly, limb salvage at 24months for RT (67%) was
significantly worse than for NR (87%, P .0001) but did not reach statistical
significance for CRI (73%, P  .058). There was a nonsignificant trend
towards improved patency results in patients with functional vs failed RT.
Conclusions: As anticipated, endovascular outcomes for patency and
limb salvage in patients with CRI were significantly worse than in patients
with NR. Restoration of renal function by transplantation does not appear to
reverse these outcomes despite the postulated beneficial effect of systemic
immunosuppression.
Repeat Angioplasty and Stenting for Femoropopliteal Occlusive
Disease: Factors Affecting Outcomes of the Second-Time Endovascular
Intervention
William P. Robinson III, Louis L. Nguyen, Richard Bafford, and Michael
Belkin, From Brigham and Women’s Hospital, Boston, Mass
Introduction: Repeat percutaneous interventions for femoropopliteal
occlusive disease are common, but the outcomes are poorly understood. We
sought to determine the results of second-time femoropopliteal percutane-
Table. High-risk composite variable analysis
Composite variable OR (95% CI)
Patent inferior mesenteric artery and
MALD 30 mm 9.15 (3.37-24.98)
6 patent LA 9.43 (3.59-24.86)
Age 70 y 9.71 (3.44-27.40)
MALD 30 mm  6 patent LA 18.49 (6.41-53.59)
MALD 30 mm  age 70 years 19.04 (6.19-8.74)
6 patent LA  age 70 years 19.62 (6.55-58.67)
MALD 30 mm  6 patent LA
 age 70 y
38.46 (11.84-125.23)
CI, Confidence interval; LA, lumbar arteries; MALD, maximum aneurysm
luminal diameter; OR, odds ratio.ous transluminal angioplasty/stenting (SPTAS) and identify factors associ-
ated with outcome.
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percutaneous lower extremity procedures at a single institution from 2002
and 2007 identified 73 SPTAS in 73 limbs. Patient comorbidities, anatomic,
and procedural characteristics were analyzed with respect to outcomes with
descriptive statistics, life-table analysis, and Cox proportional hazards mod-
eling. Patency rates were determined from the time of SPTAS.
Results: Patients included 39 men (64%) and 22 women (36%) at a
mean age of 70  10 years. Indications included claudication in 56 limbs
(77%) and critical limb ischemia in 17 (23%). Median time from the initial
endoluminal intervention to SPTAS was 322 days. Twenty limbs (27%) had
TransAtlantic Inter-Society Consensus II (TASCII) category D lesions; the
rest were treated for TASCII A, B, and C disease. Technical success was
achieved in 72 patients (99%) and initial clinical improvement in 64 (89%).
During a mean follow-up of 15.3 months, 2-year primary patency, assisted
primary patency, secondary patency, limb salvage, and survival were, respec-
tively, 66%  8%, 86%  4%, 86%  4%, 97%, and 89%. Cox proportional
hazard modeling showed that SPTAS 180 days of the initial endovascular
intervention was the only significant predictor of failure of SPTAS primary
patency (hazard ratio, 3.5; 95% confidence interval, 1.1-11). TASCII D classi-
fication was associated with failure of assisted primary and secondary patency.
Conclusions: Second-time femoropopliteal angioplasty/stenting has
excellent initial success but limited midterm primary patency. The need for
early SPTAS is highly associated with failure of primary patency and the need
for additional interventions. With vigilance, good midterm assisted primary
and secondary patency in those with limited extent of disease as well as
excellent limb salvage can be achieved.
Venous Stenting for Lower Extremity Stasis Symptoms
Saadi Alhabouni, Anil Hingorani, Enrico Ascher, Natalie Marks, Alex-
ander Shiferson, Kapil Gopal, Nirav Patel, and Theresa Jacob, From
Maimonides Medical Center, Brooklyn, NY
Introduction: In a small subset of patients presenting with severe
venous stasis disease, we have been unable to identify the sources of reflux
with standard duplex imaging of the superficial, deep, and perforating veins.
Recently, we have been examining the iliac veins with intravascular ultra-
sound (IVUS) imaging and venography to identify stenotic lesions and
reviewed our findings with this technique.
Methods: The study included 54 patients with chronic venous stasis
symptoms not responding to conventional methods of treatment, including
leg elevation, compression stockings, Unna boots, and radiofrequency ab-
lation or stripping of varicose veins, perforators, or great saphenous vein. All
patients underwent iliac-femoral venography with assessment for stenosis.
Of these, 24 (44.4%) had no detectable stenotic lesions and had no further
intervention, and 30 (55.6%) had stenotic lesions and underwent vein stenting.
The stents spanned across the inguinal ligament in all but three (90%).
Results: The venography-only group included 24 patients with an
average follow-up of 4.5 months (range, 1 week-8 months). Eleven (45.8%)
had a CEAP of 6. After 4 months, ulcers had healed in only one patient
(9.1%). The vein stenting group included 30 patients with an average
follow-up of 3.4 months (range, 1 week-10 months). Open ulcers were
present in 22 (73.3%), and in 11 (50%), the ulcers healed in an average of
3.25months (range, 1 week-8months; P .02). Complications occurred in
three patients (5.5%), including stent thrombosis in two (one with a docu-
mented hypercoagulable state, one with a suspected hypercoagulable state).
Both were reopened and restented. A superficial femoral artery pseudoan-
eurysm in one patient was repaired with a stent graft. All patients not
needing postoperative anticoagulation underwent stenting as outpatients.
Conclusion: Many patients with lower extremity venous stasis symp-
toms have a component of iliac vein stenosis, and iliac vein stenting may
especially help patients with open ulcers. In contrast to pre-existing series,
only 50% of the patients were able to have lesions identified to be stented.
The procedure is relatively simple and safe, and can be performed on an
ambulatory basis.
Aggressive Treatment of Idiopathic Axillosubclavian Vein Thrombosis
(ASVT) Provides Excellent Long-Term Function
David H. Stone, Salvatore T. Scali, Aja A. Bjerke, EvaM. Rzucidlo, Philip
P. Goodney, Adam W. Beck, and Daniel B. Walsh, From Dartmouth-
Hitchcock Medical Center, Lebanon, NH
Introduction: A multidisciplinary approach has evolved as the com-
mon therapy for axillosubclavian vein thrombosis (ASVT). Although much
attention has been devoted toward treatment paradigms, little has been
directed toward functional outcomes. This study documented long-term
functional outcomes in patients treated for ASVT.
Methods: All patients treated for ASVT at our center from 1988 to
2008 were identified. Patient demographics and comorbidities were re-
corded. Patency, freedom from reintervention, and functional outcome
were the primary end points. Follow-up by telephone contact and clinic visit
allowed quantitative comparison of functional status preoperatively and
postoperatively.Results: During the study interval, 36 patients (24 men; mean age,
32.1 years) were treated for ASVT. Seven (19.4%) were lost to follow-up.
Catheter-directed thrombolysis was used in 30 patients (83.3%), and the
average time from symptom onset to lysis was 11.8 days. Eleven patients
(30.5%) received therapy with perioperative venoplasty or selective stenting,
or both. Approaches for surgical decompression were transaxillary 19 pa-
tients (52%), supraclavicular in 11 (31%), or infraclavicular in 6 (17%). Mean
follow-up was 65 months with patency confirmed by duplex imaging in 27
of 29 (93.1%). Seven patients (19.4%) required reintervention, with four
receiving additional lytic therapy, two requiring a stent, and one venoplasty.
Time to reintervention averaged 10.7 days (range, 2-30 days) with 80.5%
freedom from reintervention during the study interval. At presentation, 19
of 29 patients (65.5%) were unable to work or perform routine activities.
After treatment, 25 (86%) returned to their employment and experienced
sustained symptomatic and functional improvement (P .001). No significant
difference was detected in functional outcome when patients were stratified by
lytic therapy, surgical approach, or need for adjunctive intervention.
Conclusions: ASVT can be successfully managed with an aggressive
multidisciplinary treatment strategy. Patients can anticipate durable ana-
tomic results with excellent long-term functional outcomes.
Endovascular Management (Percutaneous Transluminal Angioplasty)
of Patients with Critical Limb Ischemia: Long-Term Results
Robert S. Crawford, Mark F. Conrad, Lauren Hackney, Vikram Paru-
churi, Virendra I. Patel, and Richard P. Cambria, From Massachusetts
General Hospital, Boston, Mass
Introduction:Although percutaneous transluminal angioplasty (PTA)
is considered first-line therapy for peripheral vascular disease in many sce-
narios, its role in critical limb ischemia (CLI), where anatomic disease is
more extensive, remains unclear. The present study defined late (5-year)
clinical and patency data for PTA in CLI.
Methods: From January 2002 to December 2007, 447 patients un-
derwent infrainguinal angioplasty with or without a stent (PTA) for CLI
(Rutherford IV-VI). Primary patency, assisted primary patency, limb sal-
vage, and survival were assessed using Kaplan-Meier analysis. Predictors of
patency, limb salvage, and death were obtained using multivariate models.
Results: Demographics included age, 70  12 years; diabetes, 65.8%;
and dialysis, 13%. The superficial femoral artery (SFA) was treated in 58%.
Treatment in 16% was limited to the crural vessels, and 38% had multilevel
treatment. Stents were placed in 26%. Eighty percent of patients received
postprocedural clopidogrel. Mean follow-up was 28 months (range, 0-83
months). The 5-year primary and assisted patency rates were 31%  0.04%
and 75%  0.04%, respectively. Limb salvage at 5 years was 74%  0.038%;
63 patients had major amputations. Survival at 5 years was 39%  0.03%.
Multivariate analysis identified dialysis (2.7 [1.6-4.8] P .0005),1 vessel
runoff (1.5 [1.1-2.0] P  .02), and warfarin use (1.7 [1.25-2.3] P  .001)
as negative predictors of primary patency, but none of these were negative
predictors of assisted patency. Dialysis (2.5 [1.3-4.8] P  .006), female
gender (2.0 [1.1-3.7] P .02), and1 vessel runoff (1.8 [1.0-3.2] P .04)
predicted limb loss. Dialysis (2.3 [1.5-3.5] P  .0003), diabetes (1.5
[0.5-2.1] P .04), and poor runoff (1.6 [1.2-2.1] P .04) were predictors
of mortality.
Conclusion: Although primary patency is low, excellent limb salvage
rates can be achieved in patients with CLI through close follow-up and
secondary interventions. These data, and the 12% annual death rate, validate
PTA as first-line therapy CLI patients.
Surgical Repair of Complex Renal Artery Aneurysms: Favorable Out-
comes with In Situ Techniques
William P. Robinson III,Richard Bafford,Michael Belkin, andMathewT.
Menard, From Brigham and Women’s Hospital, Boston, Mass
Introduction: The optimal method of operative management of com-
plex branch renal artery aneurysms remains unclear, with recent reports
predominantly espousing ex vivo repair. We sought to determine the long-
term outcome of renal artery aneurysm (RAA) repair performed with in situ
techniques.
Methods: This is a cohort study of patients undergoing surgical repair of
RAA identified from our prospective vascular division registry (1984-2009).
Results: Twenty-six RAAs were repaired in 24 patients (17 women, 7
men; mean age, 52 16 years). Mean size was 2.3 0.7 cm (range, 0.7-4.0
cm). Twenty-three RAAs were repaired for size and three for hypertension
alone. Multiple RAAs were present in 13 patients (54%). Associated condi-
tions included hypertension in 24 (100%), fibromuscular dysplasia in 6
(25%), coexistent renal artery stenosis in 6 (25%), and aortic aneurysm in 3
(12.5%). Reconstruction in 22 RAAs (85%) involved first- or second-order
branches. In situ techniques were used in 22 repairs and included resection
combined with autogenous vein bypass or interposition in 11, primary
anastomosis to conjoined outflow vessels in 3, aortic reimplantation in 2 and
aneurysmorrhaphy combined with vein patch angioplasty in 6, exclusion in
2, tailored primary closure in 1, and autogenous bypass in 1. Four patients
